Northland, the independent institutional stockbroker and corporate adviser, is pleased to announce a co-operation agreement with Baden Hill LLP, the stockbroking partnership based in London.
Details of the full announcement can be found by following the link below:
London Stock Exchange
Northland Capital Partners is pleased to announce its appointment to provide Commissioned Research Coverage to NQ Minerals. NQ Minerals is developing its 100%-owned polymetallic Hellyer Mine, located in Tasmania. The company aims to commence production by mid-2018, with a 10-year Hellyer mine-life.
Northland Capital Partners has acted as co-lead manager in a £20,000,000 fund raise for Motif Bio (MTFB.L). The funds raised will be used to complete the REVIVE-2 Phase 3 clinical trial and file a New Drug Application and Marketing Authorisation Application in H218 to achieve marketing approval of iclaprim in the US and Europe.
Northland Capital Partners has acted as Broker in a £465,000 fund raise for PhotonStar Group (PSL.L). The net funds raised will be used to fund the proposed roll out of the halcyonPRO2 and its halcyon CloudBMS platform.